Latest

2 stories

Hide weekly roundups

Yesterday

Quarterly updateomeprazole magnesium, amoxicillin and rifabutin RedHill Biopharma Ltd.

RedHill reports H1 2026 results after Rebyota, Clenpiq deal and Talicia exit

RedHill said it funded a $12 million Rebyota and Clenpiq acquisition from Ferring using proceeds from its Talicia divestment, while advancing opaganib, RHB-204 and RHB-102 programs.

SEC filing

Tuesday, September 1

Regulatory decisionRedHill Biopharma Ltd.

RedHill details Rebyota, Clenpiq deal terms and market data for Ferring GI drugs

New filing adds royalty rates, supply terms, and clinical and market figures behind RedHill's $12 million acquisition from Ferring.

SEC filing